Longitudinal study data tracking Alzheimer’s trial cohorts demonstrated sustained cognitive stability eighteen months post-treatment initiation, with no evidence of accelerated rebound decline after medication cessation.
Neurological associations noted that durable therapeutic effects represent a critical milestone toward transforming Alzheimer’s from a terminal condition into a manageable chronic disorder.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.news2026.example.com/alzheimers-research-26